PUBLICACIÓN

The PRL3-zumab paradigm: A multicenter, single-dose-level phase 2 basket clinical trial design of an unconventional cancer immunotherapy

ACCEDER A LA PUBLICACIÓN: Orcid

2025


DOI

10.1016/j.xcrm.2025.102120


AUTORES DE LA UEX